Swiss Group for Clinical Cancer Research: Prostatic Neoplasms trials

The registry lists 15 Prostatic Neoplasms studies with Swiss Group for Clinical Cancer Research as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 9Phase 3 4No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Open-label Dose Escalation Phase 1b Trial of a New Micellar Docetaxel Compound in Patients With mCRPCTerminatedNCT04629781Phase 1
• Prostate Cancer BiobankActive, not recruitingNCT04024475
• Extended Pelvic Lymph Node Dissection vs. no Pelvic Lymph Node Dissection at Radical Prostatectomy for intermediate-and High-risk Prostate CancerTerminatedNCT03921996Phase 3
• SAKK 08/15 - PROMET - Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After ProstatectomyTerminatedNCT02945813Phase 2
• ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents.TerminatedNCT02933801Phase 2
• Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide AloneTerminatedNCT02640534Phase 2
• Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal AgentsWithdrawnNCT02053311Phase 3
• Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel TherapyCompletedNCT01707966Phase 3
• Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After SurgeryCompletedNCT01272050Phase 3
• Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate CancerCompletedNCT01243385Phase 2
• Everolimus as First-Line Therapy in Treating Patients With Prostate CancerCompletedNCT00976755Phase 2
• Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate CancerCompletedNCT00728663Phase 2
• Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate CancerCompletedNCT00031889Phase 2
• Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00006023Phase 2
• Vinorelbine in Treating Patients With Metastatic Prostate CancerCompletedNCT00003259Phase 2